Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
23,85 USD | +3,34% | +3,47% | -12,38% |
Attività
Numero di dipendenti: 346
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Genetic Medicines
100,0
%
| 61 | 100,0 % | 378 | 100,0 % | +520,01% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 61 | 100,0 % | 378 | 100,0 % | +520,01% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
John Evans
CEO | Chief Executive Officer | 46 | 01/01/17 |
President | 55 | 01/02/18 | |
Director of Finance/CFO | 47 | 01/08/19 | |
Gopi Shanker
CTO | Chief Tech/Sci/R&D Officer | - | 21/03/23 |
Amy Simon
CTO | Chief Tech/Sci/R&D Officer | 60 | 15/03/21 |
Manmohan Singh
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/07/18 |
Brian Riley
PRN | Corporate Officer/Principal | 47 | 01/09/19 |
Susan O'Connor
HRO | Human Resources Officer | 61 | 01/08/17 |
Christine Bellon
LAW | General Counsel | 59 | 01/04/19 |
Suzanne Fleming
AUD | Comptroller/Controller/Auditor | 63 | 01/02/19 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Graham Cooper
BRD | Director/Board Member | 54 | 10/10/19 |
John Maraganore
BRD | Director/Board Member | 60 | 05/11/21 |
Mark Fishman
BRD | Director/Board Member | 73 | 01/05/18 |
Kathleen Walsh
BRD | Director/Board Member | 68 | 10/01/21 |
John Evans
CEO | Chief Executive Officer | 46 | 01/01/17 |
Christi Shaw
BRD | Director/Board Member | 57 | 14/12 |
Carole Ho
BRD | Director/Board Member | 51 | 15/11/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 82 311 067 | 81 121 692 ( 98,56 %) | 0 | 98,56 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-12,38% | 1,82 Mrd | |
+17,09% | 45,34 Mrd | |
+42,10% | 40,42 Mrd | |
-9,70% | 37,92 Mrd | |
+33,28% | 31,75 Mrd | |
-8,98% | 27,71 Mrd | |
+13,37% | 26,52 Mrd | |
+44,11% | 13,96 Mrd | |
+32,33% | 12,44 Mrd | |
-7,26% | 11,26 Mrd |
- Borsa valori
- Azioni
- Azione BEAM
- Società Beam Therapeutics Inc.